GlassScriptPhysician profile
Jamie C Worsley
NPI 1417375692
$6,940.07
in general payments reported to CMS, 2019-2025
34 companies · $23.78 in 2025
The $23.78 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,709 · 2020: $1,857 · 2021: $2,169 · 2022: $1,149 · 2023: $32.32 · 2025: $23.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $787.63 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $681.66 | 2019-2022 | |
| Abbvie INC. | $534.52 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $454.51 | 2019-2022 | |
| Novo Nordisk INC | $440.86 | 2019-2022 | |
| Glaxosmithkline, LLC. | $412.16 | 2019-2022 | |
| Astellas Pharma US INC | $345.43 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $341.43 | 2019-2023 | Xifaxan |
| Janssen Pharmaceuticals, INC | $304.04 | 2019-2022 | |
| Pfizer INC. | $268.91 | 2019-2021 | |
| Allergan, INC. | $231.59 | 2019-2020 | |
| Amgen INC. | $203.84 | 2019-2021 | |
| Amarin Pharma, INC. | $203.63 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $202.44 | 2019-2022 | |
| Eisai INC. | $192.72 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $163.71 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $144.11 | 2019-2022 | |
| Esperion Therapeutics, INC. | $131.51 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $127.56 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $116.88 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $98.77 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $82.10 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $75.60 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.19 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $54.37 | 2021-2022 | |
| Dexcom, INC. | $54.01 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $38.81 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $32.14 | 2021 | |
| Exact Sciences Corporation | $23.78 | 2025 | Cologuard Collection Kit |
| Alkermes, INC. | $17.83 | 2020 | |
| Abbott Laboratories | $17.63 | 2023 | Freestyle Libre 3 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.84 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Worsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.